Cacti Asset Management LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison

Introduction:

Investment firms are required to file a quarterly report known as the 13F with the Securities and Exchange Commission (SEC). These reports provide valuable insights into the holdings and investments of these firms, allowing investors and the general public to understand their strategies and potential market trends. In this article, we will examine the Q3 2023 and Q4 2023 13F holdings comparison of Cacti Asset Management LLC, a renowned investment firm. We'll analyze the changes in their holdings, identify key stocks, and uncover any significant trends or shifts in their portfolio.

Holdings Comparison:

Cacti Asset Management LLC's Q3 2023 and Q4 2023 13F holdings reveal interesting changes in their portfolio. Let's dive into the data and examine the notable adjustments made by the firm.

1. BLACKSTONE GROUP L.P. (BX):

- Q3 2023 Shares: 870,004

- Q4 2023 Shares: 819,504

- Q3 2023 Value ($000): 92,994

- Q4 2023 Value ($000): 108,674

- Change (%): 16.9

Cacti Asset Management LLC reduced its holdings of Blackstone Group L.P. during Q4 2023, as the number of shares decreased by 50,500. However, the value of their investment increased significantly by $15,680, reflecting a positive shift in their position.

2. APPLE INC. COM (AAPL):

- Q3 2023 Shares: 557,885

- Q4 2023 Shares: 557,968

- Q3 2023 Value ($000): 95,504

- Q4 2023 Value ($000): 107,771

- Change (%): 12.8

The holdings of Apple Inc. remained relatively stable for Cacti Asset Management LLC, with only a marginal increase of 83 shares. However, the value of their investment in Apple showed a notable surge, increasing by $12,267.

3. AMERICAN EXPRESS CO (AXP):

- Q3 2023 Shares: 475,551

- Q4 2023 Shares: 437,676

- Q3 2023 Value ($000): 70,895

- Q4 2023 Value ($000): 81,871

- Change (%): 15.5

Cacti Asset Management LLC reduced its stake in American Express Co during Q4 2023, with a decrease of 37,875 shares. Nevertheless, the value of their investment grew, showing a positive change of $10,976.

4. JACOBS ENGR GROUP INC DEL (J):

- Q3 2023 Shares: 624,948

- Q4 2023 Shares: 624,948

- Q3 2023 Value ($000): 85,836

- Q4 2023 Value ($000): 81,343

- Change (%): -5.2

The holdings of Jacobs Engr Group Inc Del remained unchanged for Cacti Asset Management LLC. Despite no change in the number of shares, there was a slight decrease of $4,493 in the value of their investment.

5. GOLDMAN SACHS GROUP INC (GS):

- Q3 2023 Shares: 196,209

- Q4 2023 Shares: 196,349

- Q3 2023 Value ($000): 63,455

- Q4 2023 Value ($000): 75,492

- Change (%): 19

Cacti Asset Management LLC slightly increased its holdings of Goldman Sachs Group Inc by 140 shares in Q4 2023. The value of their investment in the company also demonstrated an upward trend, growing by $12,037.

Significant Trends and Observations:

1. Technology Sector:

- Apple Inc. (AAPL) and Microsoft Corp (MSFT) showed an increase in value for Cacti Asset Management LLC, reflecting their confidence in the technology giants.

- Seagate Technologies (STX) experienced a significant value surge of 30.1%, indicating the firm's bullish stance on the data storage industry.

2. Financial Sector:

- Goldman Sachs Group Inc (GS) saw increased investment value, showcasing Cacti Asset Management LLC's emphasis on the financial sector.

- American Express Co (AXP) and Bank of New York Mellon Corp (BK) also witnessed positive change, supporting the upward trend in the financial industry.

3. Pharma and Healthcare:

- Merck & Co Inc (MRK) and Bristol Myers Squibb Co (BMY) displayed modest growth, highlighting Cacti Asset Management LLC's continued interest in the pharmaceutical and healthcare sectors.

Conclusion:

Cacti Asset Management LLC's Q3 2023 and Q4 2023 13F holdings comparison reveals insightful changes in their portfolio. While some holdings remained constant, others experienced notable adjustments. The firm displayed confidence in the technology and financial sectors, with notable investments in companies such as Apple Inc, Microsoft Corp, and Goldman Sachs Group Inc. Additionally, their involvement in the pharmaceutical and healthcare sectors indicates a continued interest in opportunities within those industries. These observations provide valuable insights into the firm's investment strategies and potential market trends.

Disclaimer: The information provided in this article is based on publicly available data and should not be considered financial advice. Investors should conduct thorough research and consult with a qualified professional before making any investment decisions.